Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
65
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Sooyoung Shin1 College of Pharmacy, Ajou University, Yeongtong-gu, Suwon, Republic of Korea;2 Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Yeongtong-gu, Suwon, Republic of KoreaCorrespondence[email protected]
&
Yoojin Noh1 College of Pharmacy, Ajou University, Yeongtong-gu, Suwon, Republic of Korea
Pages 833-847 | Published online: 04 May 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.